Selecta Biosciences awarded grant from Bill & Melinda Gates Foundation
Clinical stage biotechnology company Selecta Biosciences has been awarded a grant from the Bill & Melinda Gates Foundation. The grant supports the research by Selecta for a novel dual action, immune-activating SVP nanoparticle vaccine for malaria.
17 June 2014•3 mins read
